Someone else's clock has started running against them: the company is being paid to solve a problem that is already cost
The model's full reasoning — Q1 2016 call → NOWe need answer question based on transcript. Need determine if management describes counterparties already losing something real and ongoing for as long as they do not have what company provides, and that this accumulating loss is visible in behavior toward company today. Need YES or NO. Let's parse transcript. Need find any instance where management describes customers/counterparties currently incurring losses/costs because they lack DuPont product, and acting urgently. Often in earnings call, no. They discuss product launches, volume growth, pricing. Need evaluate. Question asks: "On this call, does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS THEY DO NOT HAVE WHAT THIS COMPANY PROVIDES, and that this accumulating loss on the other side is ALREADY VISIBLE in how those parties are behaving toward the company today?" Need answer based solely transcript. We need look for management descriptions of customer pain due to lack of product. For example, probiotics increased sales 30% due to productivity freeing capacity to respond to strong customer demand. N&H volume growth. New products. But is there a running meter? No. Agriculture: farmers facing challenging economic conditions, but not necessarily losing due to lack of DuPont product. Jim mentions pipeline, launches. Not a running meter. Potential "Zorvec" offering disease control, "consistent long-lasting control" but no mention customers losing crops now without it. "Leptra" insect protected corn hybrids allow recapture price. No. "CRISPR-Cas advanced breeding technology" future. "Nutrition & Health" new products like protein, Greek yogurt, probiotics. Probiotics increased sales 30% as productivity freed capacity to respond to strong customer demand. That suggests demand outstripping supply? "Our productivity efforts have freed up capacity to respond to strong customer demand." But no description of customers losing something while they wait. Not enough. "Industrial Biosciences: pricing gains on new product introductions in BioActives. Increased demand for Biomaterials" no. "Electronics: Solamet paste, competitive pressures, lower demand. Tedlar film increased demand." no. "Performance Materials: lower ethylene prices etc. Demand in Asia Pacific automotive markets." no.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
SYM · Q3 2022 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...YES The transcript shows management describing customers' ongoing pain from labor shortages and broken supply chains that prevent them from handling demand, with customers actively clamoring for faster deployments and wanting the system as quickly as possible.
CRL · Q2 2022 → YESThe question is whether management describes that their counterparties are already losing something real and ongoing — money, output, access, standing, time, or an opportunity — for as long as they do...
GTES · Q4 2021 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...